Cara Therapeutics | CARA - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Acadia Pharmaceuticals USD 16.33M 28.24M 2026-09
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Cara Therapeutics USD 4.62M 1.4M 2026-03
Cassava Sciences USD 39.29M 102K 2026-06
Chugai Pharma JPY 78.17B 82.53B 2026-09
Cipla INR 32.66B 361.1M 2026-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.15M 371K 2026-06
CSL USD 3.17B 290M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 33.55M 9.94M 2026-09
J&J USD 9.32B 94M 2026-09
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Pacira USD 17.5M 4K 2026-09
Pfizer USD 4.07B 511M 2026-09
RedHill Biopharma USD 584K 147K 2026-06
Supernus Pharmaceuticals USD 8.52M 2.92M 2026-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12